Emesis: Clinical Trials

5 trials for Emesis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 1 completed, 1 terminated. 5 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Unknown 3, Completed 1, Terminated 1
Phase 12Completed 1, Unknown 1

Follow Emesis: new trials by email Literature Review of Emesis trials Research Report on Emesis

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Meclizine Orodispersible Tablet Pharmacokinetic in Human Volunteers
Meclizine Hydrochloride - Emesis
Phase 1 / Phase 2UnknownMansoura University62020-06-012020-09-25
Trial to Evaluate Efficacy of Olanzapine With Short-acting 5HT3 Inhibitors in Chemotherapy-induced Nausea & Vomiting (CINV) Prophylaxis
Olanzapine, Aprepitant Pill, Ondansetron - Emesis, Vomiting
Phase 2UnknownBlokhin's Russian Cancer Research Center1302018-05-252018-07-05
Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy
FOSAPREPITANT (Emend), Placebo - Non-small Cell Lung Cancer, Vomiting
Phase 2UnknownAjeet Gajra1502015-04-012015-04-03
Comparison of Olanzapine and Metoclopramide For Treatment Of bReakThrough Emesis
olanzapine, metoclopramide - Emesis
Phase 2TerminatedKarin Jordan232010-07-012016-05-11
Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Palonosetron in Cancer Treated With Chemotherapy
Palonosetron - Emesis
Phase 1 / Phase 2CompletedClinica Universidad de Navarra, Universidad de Navarra292009-10-012015-01-27

Narrower conditions

Vomiting (5)  ·  Nausea (2)  ·  Carcinoma, Non-Small-Cell Lung (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (5)  ·  Signs and Symptoms, Digestive (5)  ·  Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Lung Diseases (1)  ·  Lung Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Neoplasms (1)  ·  Thoracic Neoplasms (1)

Interventions

Aprepitant (2)  ·  Olanzapine (2)  ·  Dexamethasone (1)  ·  Meclizine (1)  ·  Metoclopramide (1)  ·  Ondansetron (1)  ·  Palonosetron (1)  ·  fosaprepitant (1)

Sponsors

Ajeet Gajra (1)  ·  Blokhin's Russian Cancer Research Center (1)  ·  Clinica Universidad de Navarra, Universidad de Navarra (1)  ·  Karin Jordan (1)  ·  Mansoura University (1)

Countries

Egypt (1)  ·  Germany (1)  ·  Russia (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Ajeet Gajra, MD FACP (1)  ·  Alaa Y. Darwesh, Dr (1)  ·  Belen Sadaba, MD, PhD (1)  ·  Karin Jordan, MD (1)

Results publications

PMID 16408862, PMID 23936162, PMID 24587006, PMID 25834396

NIH funding

2008 (1)